Asm. Thomas J. Abinanti

Primary A 7427

In committee · New York Assembly · Lead sponsor

Prohibits the recording of visual images of a person having a reasonable expectation of privacy while within a dwelling, when such images are recorded by another person outside the dwelling

Prohibits the recording of visual images of a person having a reasonable expectation of privacy while within a dwelling, when such images are recorded by another person outside the dwelling; makes such a violation a misdemeanor and establishes civil liability by private cause of action.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 8150

In committee · New York Assembly · Lead sponsor

Relates to the licensing of sign language interpreters and creates a state board for sign language interpreting

Relates to the licensing of sign language interpreters and creates a state board for sign language interpreting.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 7333

In committee · New York Assembly · Lead sponsor

Authorizes political subdivisions to establish demonstration programs implementing railroad grade crossing monitoring systems by means of photo devices

Authorizes political subdivisions to establish demonstration programs implementing railroad grade crossing monitoring systems by means of photo devices.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 7359

In committee · New York Assembly · Lead sponsor

Requires OPWDD to purchase and provide essential PPE to all mental health providers in the event of a declaration of a state emergency that relates to public health

Requires OPWDD to purchase and provide essential personal protection equipment to all direct support professionals, care recipients and group home providers in the event of a declaration of a state emergency that relates to public health.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 8176

In committee · New York Assembly · Lead sponsor

Enacts the New York commission for the deaf and hard of hearing act

Enacts the "New York commission for the deaf and hard of hearing act".

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 8181

In committee · New York Assembly · Lead sponsor

Relates to nominations for public office

Relates to nominations for public office without designation.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 8201

In committee · New York Assembly · Lead sponsor

Establishes a board of trustees to administer the accountants' fund for client protection of the state of New York; appropriation

Establishes a board of trustees to administer the accountants' fund for client protection of the state of New York; establishes the accountant's fund for client protection of the state of New York; relates to registration fees for accountants; makes an appropriation therefor.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 8043

In committee · New York Assembly · Lead sponsor

Directs the superintendent of state police to develop and institute arrest policies and procedures when the arrested individual has responsibility for a person with an intellectual or developmental disability

Directs the superintendent of state police to develop and institute arrest policies and procedures for instances where police are arresting an individual who has responsibility for a person with an intellectual or developmental disability.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 6605

In committee · New York Assembly · Lead sponsor

Relates to the pricing of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing

Provides that the price of single source brand-name maintenance medication for which there is no National Average Drug Acquisition Cost pricing shall be the wholesale acquisition cost.

In committee Jan 5, 2022 0 co-sponsors Track

Primary A 7076

In committee · New York Assembly · Lead sponsor

Requires insurance companies to provide coverage for monoclonal antibody treatment for the novel coronavirus (COVID-19)

Requires insurance companies to provide coverage for monoclonal antibody treatment for the novel coronavirus (COVID-19).

In committee Jan 5, 2022 0 co-sponsors Track